Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Coagulation factor X | ||
Ligand | BDBM50110749 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_49309 (CHEMBL663408) | ||
Ki | 220±n/a nM | ||
Citation | Liebeschuetz, JW; Jones, SD; Morgan, PJ; Murray, CW; Rimmer, AD; Roscoe, JM; Waszkowycz, B; Welsh, PM; Wylie, WA; Young, SC; Martin, H; Mahler, J; Brady, L; Wilkinson, K PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors. J Med Chem45:1221-32 (2002) [PubMed] | ||
More Info.: | Get all data from this article, Assay Method | ||
Coagulation factor X | |||
Name: | Coagulation factor X | ||
Synonyms: | Activated coagulation factor X (FXa) | Activated factor Xa heavy chain | Coagulation factor X precursor | Coagulation factor Xa | F10 | FA10_HUMAN | Factor X heavy chain | Factor X light chain | Factor Xa | Stuart factor | Stuart-Prower factor | ||
Type: | Enzyme | ||
Mol. Mass.: | 54726.60 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 488 | ||
Sequence: |
| ||
BDBM50110749 | |||
n/a | |||
Name | BDBM50110749 | ||
Synonyms: | CHEMBL417827 | N-{[(4-Aminomethyl-cyclohexylmethyl)-carbamoyl]-phenyl-methyl}-3-carbamimidoyl-benzamide | ||
Type | Small organic molecule | ||
Emp. Form. | C24H31N5O2 | ||
Mol. Mass. | 421.5352 | ||
SMILES | NCC1CCC(CNC(=O)[C@H](NC(=O)c2cccc(c2)C(N)=N)c2ccccc2)CC1 |wD:10.10,(12.47,-2,;11.14,-1.22,;9.8,-1.99,;8.48,-1.22,;7.13,-1.99,;7.14,-3.51,;5.79,-4.28,;4.46,-3.51,;3.13,-4.28,;3.13,-5.82,;1.8,-3.51,;.46,-4.27,;-.87,-3.51,;-.89,-1.97,;-2.2,-4.28,;-2.2,-5.84,;-3.52,-6.61,;-4.85,-5.85,;-4.87,-4.3,;-3.53,-3.53,;-6.2,-3.54,;-7.51,-4.33,;-6.22,-2,;1.01,-2.16,;2.34,-1.38,;2.32,.15,;1,.92,;-.34,.12,;-.32,-1.41,;8.48,-4.3,;9.8,-3.53,)| | ||
Structure |